David Sinclair· PhD
In two types of AD mouse models, raising NAD+ levels reversed major pathologies, recovered cognitive function, and normalized levels of p-tau 217, a biomarker of AD in humans
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
In two types of AD mouse models, raising NAD+ levels reversed major pathologies, recovered cognitive function, and normalized levels of p-tau 217, a biomarker of AD in humans
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Restoring brain NAD+ homeostasis reverses advanced AD in mice
NAD+ balance dysregulation correlates with AD severity in mice and humans, and comparing NAD+’s effects on AD mice and humans’ proteins highlights reversal nodes.
So, at least in mice, a couple of labs have published now in top journals like "Cell" that raising the NAD levels in the brain also improves memory and slows down the advancement of Alzheimer's.